{"corpus_id":15038880,"paper_sha":"36783a2f7933480d8325b05ce3d7f096d408300a","doi":null,"arxiv_id":null,"pmid":26322209,"pmcid":"4530192","mag_id":2412612742,"dblp_id":null,"acl_id":null,"title":"A Study of the Prevalence of Psychiatric Disorders in Patients with Methamphetamine-Induced Psychosis","year":2015,"publication_date":null,"venue":"addiction and health","journal":{"name":"Addiction & Health","pages":"37 - 46","volume":"7"},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article"],"s2_fields_of_study":["Medicine","Psychology"],"reference_count":36,"citation_count":40,"influential_citation_count":2,"is_open_access":false,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":null,"chemicals":null,"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":null,"s2_open_access_landing_url":null,"s2_open_access_license":null,"s2_open_access_status":null,"pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"Background The abuse of narcotic drugs and psychotropic substances such as amphetamines and ecstasy has had a growing trend. Tachycardia, increased blood pressure, hallucinations, panic attacks, and psychosis are the negative effects of methamphetamine abuse. The present study aimed to assess psychiatric disorders associated with methamphetamine-induced psychotic disorder. Methods This cross-sectional study was performed from October 2013 to March 2014 on 165 patients hospitalized at Shahid Beheshti Hospital in Kerman, Iran, and diagnosed with psychosis induced by methamphetamine abuse within the previous 6 months. Study subjects were selected via census method. Based on the exclusion criteria and due to the lack of cooperation of some patients, 121 patients were enrolled in the study. Research data were gathered using clinical interviews, the Yale-Brown obsessive compulsive scale (Y-BOCS), Hamilton anxiety scale (HAM-A) and Hamilton rating scale for depression (HRSD), Young mania rating scale (YMRS), substance dependence severity scale (SDSS), positive and negative syndrome scale (PANSS), and clinical global impression (CGI) scale. The data analysis was performed using SPSS software, descriptive statistics, and ANOVA. Findings Among the 121 patients of the sample group, 4 patients (3.3%) had anxiety, 58 patients (47.9%) depression, 30 patients (24.8%) obsessive-compulsive disorder (OCD), 20 patients (16.5%) bipolar mood disorder (BMD), 8 patients (6.6%) persistent psychotic symptoms, 85 patients (70.2%) personality disorder, and 36 patients (29.8%) had no personality disorders. The highest prevalence was related to borderline personality disorder (35.5%). However, 45 patients (37.2%) had no impairment associated with methamphetamine-induced psychosis. Conclusion It seems that there is comorbidity between psychiatric disorders, including mood disorders, especially depressive disorder, childhood history of attention deficit hyperactivity disorder (ADHD), bipolar disorder, and personality disorders such as borderline personality disorder, and antisocial personality disorders, and methamphetamine abuse.","claims":[{"public_id":"cl_4a8ffe1a6d470bd260cd26c811b5bad9","status":"active","text":"A substantial subset of patients, 37.2%, had no impairment associated with methamphetamine-induced psychosis.","confidence":0.94,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_4a8ffe1a6d470bd260cd26c811b5bad9"},{"public_id":"cl_bd159051213239b4877a814118597379","status":"active","text":"Among 121 patients with methamphetamine-induced psychosis, depression was the most common psychiatric disorder at 47.9%.","confidence":0.98,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_bd159051213239b4877a814118597379"},{"public_id":"cl_1fba64c2921e198f9e772542ef014819","status":"active","text":"Anxiety, obsessive-compulsive disorder, bipolar mood disorder, and persistent psychotic symptoms were also observed, with prevalences of 3.3%, 24.8%, 16.5%, and 6.6% respectively.","confidence":0.96,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_1fba64c2921e198f9e772542ef014819"},{"public_id":"cl_65058f92936ab583b899ccd7fb4c7e50","status":"active","text":"Comorbidity appears to exist between methamphetamine abuse and psychiatric disorders, especially depressive disorder, bipolar disorder, and borderline and antisocial personality disorders.","confidence":0.81,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_65058f92936ab583b899ccd7fb4c7e50"},{"public_id":"cl_f729bed6cfc4af29023046f70b2998f9","status":"active","text":"Personality disorders were present in 70.2% of the sample, with borderline personality disorder showing the highest prevalence at 35.5%.","confidence":0.97,"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/claims/cl_f729bed6cfc4af29023046f70b2998f9"}],"concepts":[{"public_id":"co_02f9c811ee8c2074fee923c1a4fa39d8","status":"active","name":"personality disorder","description":"A category of enduring maladaptive personality patterns assessed in the sample.","types":["psychiatric disorder"],"aliases":["personality disorders"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_02f9c811ee8c2074fee923c1a4fa39d8"},{"public_id":"co_054720347959c35a4d9cd1a5b5dde4a4","status":"active","name":"bipolar mood disorder","description":"A mood disorder involving episodes of mania or hypomania and depression.","types":["psychiatric disorder"],"aliases":["BMD","bipolar disorder"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_054720347959c35a4d9cd1a5b5dde4a4"},{"public_id":"co_15641d716860ac4685375689bfaf86b6","status":"active","name":"methamphetamine-induced psychosis","description":"A psychotic disorder diagnosed in the context of methamphetamine abuse.","types":["condition"],"aliases":["psychosis induced by methamphetamine abuse","methamphetamine-induced psychotic disorder"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_15641d716860ac4685375689bfaf86b6"},{"public_id":"co_314de44b3d7dbfa605604c2246f7e83f","status":"active","name":"persistent psychotic symptoms","description":"Ongoing psychotic symptoms present beyond the acute phase.","types":["symptom"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_314de44b3d7dbfa605604c2246f7e83f"},{"public_id":"co_3ac122d0d03c508ebe57da86999dfdf0","status":"active","name":"borderline personality disorder","description":"A personality disorder marked by instability in emotions, relationships, and self-image.","types":["psychiatric disorder"],"aliases":["BPD"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_3ac122d0d03c508ebe57da86999dfdf0"},{"public_id":"co_712fdd6584a4c90cdc0ce929a423e2f6","status":"active","name":"obsessive-compulsive disorder","description":"A disorder characterized by obsessions and compulsions.","types":["psychiatric disorder"],"aliases":["OCD"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_712fdd6584a4c90cdc0ce929a423e2f6"},{"public_id":"co_749d17f1731a082018a5b4e6d3352817","status":"active","name":"methamphetamine abuse","description":"Use of methamphetamine examined as the exposure linked to psychotic and psychiatric outcomes.","types":["exposure"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_749d17f1731a082018a5b4e6d3352817"},{"public_id":"co_7fb5781a74871c6be9989e4903243a0b","status":"active","name":"anxiety","description":"An anxiety disorder identified by clinical assessment in the sample.","types":["psychiatric disorder"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_7fb5781a74871c6be9989e4903243a0b"},{"public_id":"co_c0aa8a3fb25bc7cfab83dfa7dd194c7d","status":"active","name":"psychiatric disorders","description":"Mental health disorders assessed as comorbidities in patients with methamphetamine-induced psychosis.","types":["disease category"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_c0aa8a3fb25bc7cfab83dfa7dd194c7d"},{"public_id":"co_cc07729f17d95397ed5899d4607c67a4","status":"active","name":"121 patients","description":"The enrolled study sample after exclusions and nonparticipation.","types":["study sample"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_cc07729f17d95397ed5899d4607c67a4"},{"public_id":"co_df13a91961858083c087093377a8ccd0","status":"active","name":"impairment","description":"Functional impairment associated with methamphetamine-induced psychosis as assessed in the study.","types":["outcome"],"aliases":[],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_df13a91961858083c087093377a8ccd0"},{"public_id":"co_fe1d3ec51bad497e445643d54e061d03","status":"active","name":"depression","description":"A mood disorder characterized by persistent low mood and related symptoms.","types":["psychiatric disorder"],"aliases":["depressive disorder"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"url":"https://sah.borca.ai/concepts/co_fe1d3ec51bad497e445643d54e061d03"}],"external_ids":{"DOI":null,"ArXiv":null,"PubMed":26322209,"PubMedCentral":"4530192","MAG":2412612742,"DBLP":null,"ACL":null},"open_access":{"is_open_access":false,"pdf_url":null,"landing_url":"https://sah.borca.ai/papers/15038880","source":null,"pdf_url_source":null,"license":null,"reason":"pdf_url_not_indexed"},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":632790,"paper_uid":"631e61c4-1b3d-4cb8-b0a8-6358d3fb16eb","canonical_identity":{"paper_id":632790,"paper_uid":"631e61c4-1b3d-4cb8-b0a8-6358d3fb16eb","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/15038880"}